gabexate has been researched along with Complications, Labor in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coagulation studies revealed disseminated intravascular coagulation and a diagnosis of amniotic fluid embolism was made." | 1.26 | Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY. ( Kawai, M; Kosaki, G; Shimada, Y; Taenaka, N; Yoshiya, I, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taenaka, N | 1 |
| Shimada, Y | 1 |
| Kawai, M | 1 |
| Yoshiya, I | 1 |
| Kosaki, G | 1 |
1 other study available for gabexate and Complications, Labor
| Article | Year |
|---|---|
Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY.
Topics: Adult; Blood Transfusion; Disseminated Intravascular Coagulation; Embolism, Amniotic Fluid; Female; | 1981 |